Mathias Berndt Selected Research

elarofiban

6/2018

Glycoprotein IIb/IIIa receptor imaging with 18F-GP1 positron emission tomography for acute venous thromboembolism: an open-label, non-randomized, first-in-human phase 1 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mathias Berndt Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 01/2011
2	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 07/2021 - 10/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 10/2012
2	Tauopathies 01/2021 - 09/2019
2	Thrombosis (Thrombus) 06/2018 - 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Breast Neoplasms (Breast Cancer) 07/2021
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021
1	Pick Disease of the Brain (Pick's Disease) 01/2021
1	Corticobasal Degeneration 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2020
1	Colorectal Neoplasms (Colorectal Cancer) 08/2020
1	Thromboembolism 05/2019
1	Blood Vessel Dissection 01/2019
1	Abdominal Aortic Aneurysm 01/2019
1	Cerebral Infarction 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Venous Thromboembolism 06/2018
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Parkinson Disease (Parkinson's Disease) 10/2012
1	Frontotemporal Dementia (Semantic Dementia) 10/2012
1	Dementia (Dementias) 10/2012
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 10/2012
1	Inflammation (Inflammations) 09/2011
1	Hepatocellular Carcinoma (Hepatoma) 01/2007

Drug/Important Bio-Agent (IBA)

9	Glutamic Acid (Glutamate)FDA Link 01/2022 - 01/2011
3	Amino Acids FDA Link 01/2022 - 01/2011
3	4-(3-fluoropropyl)glutamic acidIBA 01/2022 - 01/2019
3	RadiopharmaceuticalsIBA 10/2020 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2011
2	Platelet Membrane GlycoproteinsIBA 05/2019 - 06/2018
2	Glycoproteins (Glycoprotein)IBA 05/2019 - 06/2018
1	liposomal doxorubicin (Doxil)FDA Link 01/2022
1	Cystine (L-Cystine)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	AntiportersIBA 01/2022
1	Radioisotopes (Radionuclides)IBA 07/2021
1	Bombesin Receptors (Bombesin Receptor)IBA 07/2021
1	PI-2620IBA 01/2021
1	Amyloid beta-PeptidesIBA 09/2019
1	PropionatesIBA 05/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	elarofibanIBA 06/2018
1	Platelet Glycoprotein GPIIb-IIIa ComplexIBA 01/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2016
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 10/2012
1	Amyloid (Amyloid Fibrils)IBA 10/2012
1	SynucleinsIBA 10/2012
1	EmulsionsIBA 10/2012
1	(4S)-4-(3-(18F)fluoropropyl)-L-glutamateIBA 09/2011
1	TurpentineIBA 09/2011
1	AcidsIBA 01/2011
1	Glutamine (L-Glutamine)FDA Link 01/2011
1	oxidized low density lipoproteinIBA 01/2007
1	N- (6- (4- fluorobenzylidene)aminooxyhexyl)maleimideIBA 01/2007

Therapy/Procedure

2	Therapeutics 07/2021 - 01/2019
1	Endarterectomy (Thromboendarterectomy) 01/2019
1	Stents 01/2019
1	Catheters 01/2017